"It’s very fulfilling to work at a place like Genentech where I am constantly inspired to grow and innovate."
I joined the Antibody Engineering Department at Genentech in 2020 after completing my postdoctoral work at UCSF where I investigated antibody-based strategies to target disease-specific neo-epitopes. Prior to this, I completed my graduate studies at UC Berkeley in protein biophysics.
I was drawn to Genentech because I wanted to be part of a scientific community with a strong commitment and proven track-record for delivering life-changing medicines for patients. I feel incredibly fortunate to collaborate with talented colleagues across the organization to discover and engineer the next generation of biotherapeutics.
2022, Advanced Drug Delivery Reviews, 182, 114112.
2022, Journal of Clinical Investigation, 132, e154604.